Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/6/2025

Small Airway Disease Definition and Characteristics

Anatomical Definition

  • Small airways are defined as those with an internal diameter ≤2 mm without cartilage in their walls, including the membranous and respiratory bronchioles, which are distal to the terminal bronchioles 1, 2, 3, 4

Pathological Features

  • The disease manifests through three key pathological processes: cellular inflammation (lymphocytic, neutrophilic, eosinophilic, or granulomatous), fibrosis, and architectural distortion, leading to airway narrowing, obliteration, and eventual complete airway loss 1, 2, 4, 5
  • In asbestos-related small airway disease, inflammation and fibrosis occur in the walls of membranous bronchioles with smooth muscle hyperplasia, while respiratory bronchioles show fibrosis extending into alveolated portions 4

Clinical Significance

  • Small airway disease can cause cough with or without mucous hypersecretion and bronchial hyperresponsiveness, and may result in incomplete or irreversible airflow limitation 1, 3, 6

Diagnostic Challenges

  • HRCT resolution is limited to airways >2 mm in diameter, so normal bronchioles cannot be visualized, and chest radiographs are often normal despite clinically significant bronchiolar disease 2, 6
  • Direct HRCT signs include airway dilation, wall thickening, nodular branching (2-4 mm), and tree-in-bud abnormalities, while indirect HRCT signs include air-trapping (mosaic attenuation on expiratory scans) and subsegmental atelectasis 2, 6, 7
  • Small airway disease must be distinguished from conditions affecting larger airways, such as asthma, COPD/emphysema, and bronchiectasis, and excludes bronchiolar abnormalities associated with these conditions when they are the primary diagnoses 1, 9
  • In COPD, small airway disease represents the airway component (inflammation, increased wall muscle mass, fibrosis, narrowing) as distinct from emphysema (parenchymal destruction) 5

Associated Conditions

  • Small airway disease occurs in multiple clinical contexts, including nonbronchiectatic suppurative airway disease (bronchiolitis), inflammatory bowel disease-related lung involvement, diffuse panbronchiolitis, asbestos exposure, connective tissue diseases, and post-infectious states 1, 4, 10, 11, 12

REFERENCES

4

diagnosis and initial management of nonmalignant diseases related to asbestos. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2004

5

Emphysema and COPD Pathophysiology [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025